Cite
Sermet-Gaudelus I, Renouil M, Fajac A, et al. Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med. 2018;16(1):159doi: 10.1186/s12916-018-1138-z.
Sermet-Gaudelus, I., Renouil, M., Fajac, A., Bidou, L., Parbaille, B., Pierrot, S., Davy, N., Bismuth, E., Reinert, P., Lenoir, G., Lesure, J. F., Rousset, J. P., & Edelman, A. (2018). Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC medicine, 16(1), 159. https://doi.org/10.1186/s12916-018-1138-z
Sermet-Gaudelus, I, et al. "Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study." BMC medicine vol. 16,1 (2018): 159. doi: https://doi.org/10.1186/s12916-018-1138-z
Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, Davy N, Bismuth E, Reinert P, Lenoir G, Lesure JF, Rousset JP, Edelman A. Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med. 2018 Aug 25;16(1):159. doi: 10.1186/s12916-018-1138-z. PMID: 30143037; PMCID: PMC6109304.
Copy
Download .nbib